Ströhlein, M., Lordick, F., Rüttinger, D., Grützner, K., Schemanski, O. C., Jäger, M., . . . Heiss, M. M. (2011). Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: An open-label, multicenter, phase I/II trial. Onkologie, 34(3), . https://doi.org/10.1159/000324667
Chicago-Zitierstil (17. Ausg.)Ströhlein, Michael, et al. "Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-label, Multicenter, Phase I/II Trial." Onkologie 34, no. 3 (2011). https://doi.org/10.1159/000324667.
MLA-Zitierstil (9. Ausg.)Ströhlein, Michael, et al. "Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-label, Multicenter, Phase I/II Trial." Onkologie, vol. 34, no. 3, 2011, https://doi.org/10.1159/000324667.